BRANCHAMIN 4% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Branchamin 4%, and what generic alternatives are available?
Branchamin 4% is a drug marketed by Baxter Hlthcare and is included in two NDAs.
The generic ingredient in BRANCHAMIN 4% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Branchamin 4%
A generic version of BRANCHAMIN 4% was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for BRANCHAMIN 4%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BRANCHAMIN 4% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BRANCHAMIN 4%
US Patents and Regulatory Information for BRANCHAMIN 4%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | BRANCHAMIN 4% | amino acids | INJECTABLE;INJECTION | 018678-001 | Sep 28, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Baxter Hlthcare | BRANCHAMIN 4% IN PLASTIC CONTAINER | amino acids | INJECTABLE;INJECTION | 018684-001 | Sep 28, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BRANCHAMIN 4%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | BRANCHAMIN 4% | amino acids | INJECTABLE;INJECTION | 018678-001 | Sep 28, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BRANCHAMIN 4%
See the table below for patents covering BRANCHAMIN 4% around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 7456581 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 8200411 | ⤷ Try a Trial | |
European Patent Office | 0057209 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for BRANCHAMIN 4%
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0484186 | CR 2011 00031 | Denmark | ⤷ Try a Trial | PRODUCT NAME: 4-AMINOPYRIDIN ELLER ET SALT DERAF, HERUNDER FAMPRIDIN; REG. NO/DATE: EU/1/11/699/001-002 20110720 |
1870100 | 2012/024 | Ireland | ⤷ Try a Trial | PRODUCT NAME: ETHYL 3-((2-(4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)- PHENYLAMINO)-METHY)-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)- PYRIDIN-2-YL-AMINO)-PROPIONATE METHANESULPHONATE |
2340828 | LUC00195 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: SACUBITRIL ET VALSARTAN, SOUS FORME DE COMPLEXE DE SEL DE SODIUM SACUBITRIL VALSARTAN, C'EST-A-DIRE (((S)-N-VALERYL-N-((2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL)-METHYL)-VALINE) ((2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-ESTER ETHYLIQUE D'ACIDE PENTANOIQUE))NA3 X H2O, DANS LEQUEL X EST 0 A 3; AUTHORISATION NUMBER AND DATE: EU/1/15/1058 20151123 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |